Level 1 – Theoretical Certification in Botulinum Toxin Type A

16-Hour Foundational Course for Dentists

​

Required before any hands-on or clinical injectable training

At Montréal AestheticS Academy (MASA), Level 1 is the first step for dentists who wish to build a solid foundation in injectable medicine. This 16-hour theoretical certification introduces the essential scientific, anatomical, clinical, and safety principles related to Botulinum Toxin Type A (BoNT/A) in facial aesthetics and selected therapeutic applications.

This course is designed for dentists who want to begin their training pathway in facial aesthetics while following a structured and responsible educational approach aligned with professional guidelines.

​

Important Notice

Completion of Level 1 does not authorize the dentist to perform aesthetic or therapeutic injections.

​

This course is a theoretical prerequisite required before progressing to MASA’s advanced clinical and hands-on training levels.

​

What You Will Learn

​

1. Head and Neck Anatomy

Participants review the key anatomical structures relevant to facial injectable medicine, including facial muscles, vascular anatomy, nervous system pathways, skin layers, and the temporomandibular joint.

​

2. Facial Aging and Treatment Planning

The course explains how facial aging, tissue changes, muscle activity, and structural support influence aesthetic assessment and treatment planning.

​

3. Dental, Orofacial, and Facial Assessment

Participants learn how to approach a comprehensive evaluation of the oral region, perioral structures, facial soft tissues, and surrounding anatomical areas relevant to aesthetic and therapeutic cases.

​

4. Anatomical Mapping Techniques

The course introduces theoretical methods for facial palpation, surface marking, anatomical landmark identification, and injection-site planning.

​

5. Calibrated Aesthetic Photography

Participants are introduced to standardized clinical photography, documentation principles, and the use of before-and-after images for medical records and treatment planning.

​

6. Botulinum Toxin Type A in Treatment Planning

The course reviews how BoNT/A may be integrated theoretically into aesthetic and orofacial treatment plans, while emphasizing patient selection, safety, and professional responsibility.

​

7. Indications and Contraindications

Participants learn about appropriate indications, contraindications, patient selection, ethical considerations, and limitations related to BoNT/A treatment.

​

8. Safety and Complication Management

The course covers risk factors, prevention strategies, patient safety protocols, adverse effects, and the theoretical management of possible complications.

​

9. Outcome Evaluation and Follow-Up

Participants learn the principles of treatment evaluation, patient follow-up, documentation, and clinical reasoning for future treatment planning.

​

Who This Course Is For

This course is designed specifically for dentists who are beginning their educational pathway in injectable medicine.

It provides the essential theoretical foundation required before advancing to hands-on training in aesthetic and therapeutic applications of Botulinum Toxin Type A.

​

Course Objective

By the end of this course, participants will have a structured theoretical understanding of facial anatomy, patient assessment, treatment planning, safety principles, contraindications, complications, and documentation requirements related to BoNT/A.

This foundation prepares dentists to progress responsibly toward advanced clinical training levels.

Level 2 – Clinical Training in Botulinum Toxin Type A

Upper Face Aesthetic Treatment and Bruxism Management

Hybrid Course: 8 Hours Theory + 8 Hours Hands-On Training

Includes supervised clinical practice on 6 patients

At Montréal AestheticS Academy (MASA), Level 2 introduces the first hands-on clinical training stage for dentists. This course is designed for licensed dentists who have completed Level 1 and are ready to begin supervised clinical application of Botulinum Toxin Type A (BoNT/A).

Level 2 focuses on the aesthetic treatment of the upper face and the therapeutic use of BoNT/A for bruxism, with a strong emphasis on patient assessment, anatomy, safety, treatment planning, informed consent, and complication prevention.

This course combines structured medical theory with supervised hands-on training in a controlled clinical learning environment.

​

Important Notice

Level 2 is intended for dentists who have successfully completed the required Level 1 theoretical certification.

​

The course is designed to support a responsible training pathway aligned with professional standards and the expectations of the Ordre des dentistes du Québec (ODQ) for injectable training.

​

Course Structure

​

Theory Component – 8 Hours​

The theoretical component provides the clinical knowledge required before performing supervised injections. Participants review anatomy, patient assessment, pharmacology, indications, contraindications, risk management, documentation, and treatment planning.

​

Hands-On Component – 8 Hours

The hands-on component includes supervised clinical application on 6 patients. Participants observe, assess, plan, document, and perform injections under professional supervision according to the level of training and treatment indications covered in this course.

​

What You Will Learn

​

1. Patient Assessment and Clinical Diagnosis

Participants learn how to perform a complete evaluation before any injectable treatment. This includes reviewing the patient’s medical history, identifying relevant risk factors, evaluating aesthetic concerns, and assessing therapeutic indications such as bruxism.

Topics include:

• Medical history review related to BoNT/A treatment

• Comprehensive aesthetic and therapeutic patient evaluation

• Assessment of upper facial muscle activity

• Evaluation of masseter muscle function

• Understanding the causes and classifications of bruxism

• Diagnosis of aesthetic facial concerns and muscular dysfunction

• Patient selection and treatment suitability

​

2. Clinical Photography and Documentation

Participants are introduced to standardized documentation methods used in injectable medicine.

Topics include:

• Calibrated clinical photography

• Before-and-after documentation principles

• Standardized upper face photography

• Documentation for medical records

• Use of photography for treatment planning and follow-up

​

3. Pharmacology, Safety, and Risk Management

This section focuses on the safe use of Botulinum Toxin Type A in aesthetic and therapeutic contexts.

Topics include:

• Pharmacology of BoNT/A

• Mechanism of action

• Product preparation and handling

• Dilution principles

• Sterile technique in injectable procedures

• Safety assessment before treatment

• Contraindications and precautions

• Prevention of complications

• Recognition and management of adverse effects

Possible complications discussed include:

• Eyelid or brow ptosis

• Unwanted muscle weakness

• Facial asymmetry

• Unsatisfactory clinical response

• Bruising, swelling, or local reaction

• Rare adverse reactions requiring further assessment or referral

​

4. Treatment Planning and Injection Techniques

Participants learn how to develop treatment plans for the upper face and bruxism using BoNT/A.

Treatment areas include:

• Forehead lines

• Glabellar lines

• Crow’s feet

• Masseter muscles for bruxism-related concerns

Topics include:

• Anatomical landmarks

• Injection-site planning

• Dose planning

• Muscle mapping

• Preparation and dilution

• Injection technique

• Treatment sequencing

• Patient-specific treatment adjustments

• Recognition of treatment limitations

• When to refer complex or advanced cases

​

5. Bruxism and Masseter Treatment

This section focuses on the theoretical and clinical use of BoNT/A for selected bruxism-related cases.

Topics include:

• Understanding bruxism and muscular hyperactivity

• Masseter anatomy and function

• Patient evaluation for therapeutic treatment

• Dose planning and injection sites

• Expected timeline and follow-up

• Treatment limitations

• Integration with dental care planning

• Referral considerations when indicated

​

6. Outcome Evaluation and Follow-Up

Participants learn how to evaluate treatment response and determine appropriate follow-up.

Topics include:

• Clinical response assessment

• Patient follow-up after treatment

• Documentation of outcomes

• Identifying asymmetry or insufficient response

• Determining whether adjustment is appropriate

• Patient education after treatment

• Long-term treatment planning considerations

​

7. Patient Communication and Informed Consent

Effective communication and proper consent are essential parts of clinical injectable practice.

Topics include:

• Providing clear patient information

• Explaining benefits, risks, limitations, and alternatives

• Discussing expected timelines and variability of results

• Obtaining informed consent

• Providing post-treatment instructions

• Managing patient expectations

• Communicating when treatment is not appropriate

​

8. Practice Management and Team Preparation

This section reviews the clinic workflow needed to support safe and organized injectable treatments.

Topics include:

• Patient information sheets

• Staff preparation before and after treatment

• Treatment room preparation

• Infection prevention measures

• Documentation workflow

• Photography protocol

• Post-treatment patient support

• Emergency preparedness and referral pathways

​

Who This Course Is For

This course is designed for licensed dentists who have completed MASA Level 1 and are ready to begin supervised clinical training in Botulinum Toxin Type A.

It is appropriate for dentists who want to develop skills in:

• Upper face aesthetic BoNT/A treatment

• Bruxism-related masseter treatment

• Patient assessment and clinical diagnosis

• Safe injection planning

• Medical documentation

• Informed consent and patient communication

​

Course Objective

By the end of Level 2, participants will have strengthened their ability to assess patients, plan BoNT/A treatments, understand dosing and anatomical landmarks, apply safety principles, document care appropriately, and perform selected injections under supervision within the scope of this training level.

This course prepares dentists to continue progressing through MASA’s advanced injectable training pathway.

Level 3 – Advanced Clinical Training in Botulinum Toxin Type A

Mid-Face, Lower Face, Neck, and Myofascial Applications

Hybrid Course: 8 Hours Theory + 8 Hours Clinical Training

Includes supervised clinical practice on 6 patients

At Montréal AestheticS Academy (MASA), Level 3 is an advanced Botulinum Toxin Type A training course designed for licensed dentists who have completed MASA Levels 1 and 2 and are ready to expand their clinical knowledge into more complex facial and therapeutic treatment areas.

This course focuses on the advanced use of Botulinum Toxin Type A (BoNT/A) for selected aesthetic and therapeutic applications involving the mid-face, lower face, neck, masseter region, and myofascial dysfunctions.

Participants review advanced anatomy, patient assessment, treatment planning, injection-site mapping, risk management, documentation, and supervised clinical application.

​

Important Notice

Level 3 is MASA’s advanced neuromodulator course before dermal filler training.

​This course is intended for dentists who have already completed the required theoretical and clinical training pathway in Levels 1 and 2. It is designed to support continued development in accordance with professional expectations and the training progression outlined for dental professionals.

​

Dermal fillers may be introduced theoretically during this course; however, filler injections are not part of Level 3 certification. Dermal filler clinical training is covered in Level 4.

​

Course Structure

​Theory Component – 8 Hours

The theory component reviews advanced facial anatomy, pharmacology, patient assessment, treatment planning, safety, complications, therapeutic indications, aesthetic indications, and clinical decision-making.

​

Clinical Component – 8 Hours

The clinical component includes supervised clinical training on 6 patients. Participants apply assessment, documentation, photography, treatment planning, and selected injection techniques under professional supervision.

​

What You Will Learn

​

1. Advanced Anatomy and Pharmacology

Participants review the anatomical structures involved in advanced BoNT/A treatment planning.

Topics include:

• Skeletal and muscular anatomy of the mid-face and lower face

• Oral and perioral anatomy

• Neck anatomy and platysma region

• Masseter and mandibular region

• Skull base and surrounding muscular structures

• Facial nerve pathways and vascular considerations

• Advanced pharmacology of Botulinum Toxin Type A

• Dilution principles and dosing considerations

• Product handling and treatment planning strategies

• Introduction to dermal fillers from a theoretical perspective only

​

2. Full Patient Assessment and Diagnosis

This section focuses on evaluating patients for more complex aesthetic and therapeutic indications.

Topics include:

• Medical history review for mid-face, lower face, neck, and myofascial treatments

• Assessment of facial muscle activity

• Evaluation of facial asymmetry and functional concerns

• Assessment of masseter hyperactivity and bruxism-related concerns

• Evaluation of myofascial pain and trigger points

• Calibrated photography of treatment areas

• Patient selection and treatment suitability

• Recognition of treatment limitations and referral indications

Clinical concerns reviewed may include:

• Gummy smile

• Bruxism and jaw muscle hyperactivity

• Masseter hypertrophy

• Myofascial trigger points

• Lower face muscular hyperactivity

• Mentalis hyperactivity

• Depressor anguli oris activity

• Neck lines and platysmal bands

​

3. Treatment Planning and Injection Techniques

Participants learn how to create comprehensive aesthetic and therapeutic treatment plans using BoNT/A.

Topics include:

• Patient-specific treatment planning

• Indications and contraindications

• Anatomical landmark identification

• Injection-site mapping

• Dose planning and dilution principles

• Treatment sequencing

• Adjusting plans based on anatomy and muscle activity

• Combining aesthetic and therapeutic objectives responsibly

• Understanding when treatment is not appropriate

• Referral to specialists when cases exceed the dentist’s scope or training level

Treatment areas and indications may include:

• Gummy smile treatment planning

• Lower face muscle modulation

• Mentalis treatment planning

• Depressor anguli oris treatment planning

• Masseter treatment for selected cases

• Platysmal bands and neck-related concerns

• Myofascial pain and trigger point approaches

​

4. Myofascial Pain and Therapeutic Applications

This section reviews the use of BoNT/A in selected therapeutic contexts relevant to dental and orofacial practice.

Topics include:

• Myofascial dysfunction assessment

• Trigger point identification

• Muscular hyperactivity patterns

• Bruxism-related muscular concerns

• Masseter and temporomandibular region considerations

• Pain-related treatment planning

• Patient follow-up and outcome evaluation

• Multidisciplinary referral when indicated

​

5. Risk Management and Complication Prevention

Advanced areas such as the lower face and neck require careful assessment, precise technique, and risk awareness.

Topics include:

• Prevention of adverse effects

• Recognition of facial asymmetry

• Unwanted muscle weakness

• Swallowing or speech-related concerns in neck/lower face treatments

• Bruising, swelling, or local reactions

• Patient-specific risk factors

• Safety considerations for complex anatomical regions

• Emergency and referral protocols

• Continuous reassessment for safety and clinical response

​

6. Clinical Photography, Documentation, and Follow-Up

Participants learn how to document advanced treatments clearly and consistently.

Topics include:

• Standardized clinical photography

• Before-and-after documentation

• Treatment records

• Informed consent documentation

• Dose and site charting

• Follow-up assessment

• Patient-reported feedback

• Evaluation of treatment response

• Documentation of adverse events or limitations

​

7. Patient Communication and Informed Consent

Clear communication is essential when treating advanced aesthetic and therapeutic areas.

Topics include:

• Explaining treatment objectives

• Discussing risks, benefits, limitations, and alternatives

• Managing expectations

• Educating patients on post-treatment care

• Providing written information and aftercare instructions

• Obtaining informed consent before treatment

• Discussing when referral or alternative treatment is more appropriate

​

8. Practice Integration and Team Preparation

This section reviews how to integrate advanced BoNT/A services into a dental or aesthetic practice safely and professionally.

Topics include:

• Patient workflow

• Staff preparation before and after treatment

• Assistant education and support

• Treatment room preparation

• Infection prevention standards

• Patient information sheets

• Post-treatment instructions

• Ethical and legal considerations

• Safe expansion into therapeutic and aesthetic injectable services

​

Who This Course Is For

​Level 3 is designed for licensed dentists who have completed MASA Levels 1 and 2 and are ready to expand into more advanced neuromodulator applications.

This course is appropriate for dentists interested in:

• Mid-face and lower face BoNT/A treatment planning

• Neck and platysmal band treatment considerations

• Myofascial pain and muscular dysfunction

• Bruxism-related advanced assessment

• Gummy smile treatment planning

• Lower face muscle hyperactivity

• Therapeutic and aesthetic applications of BoNT/A

• Advanced patient assessment and documentation

​

Course Objective

​By the end of Level 3, participants will have developed a more advanced understanding of BoNT/A applications for the mid-face, lower face, neck, and selected therapeutic conditions.

Participants will strengthen their skills in advanced anatomy, clinical diagnosis, treatment planning, dose selection, injection-site mapping, complication prevention, informed consent, documentation, and supervised clinical application.

This course prepares dentists to continue progressing toward MASA’s dermal filler training pathway in Level 4.

Level 4 – Clinical Training in Dermal Fillers

Lips, Vermilion Border, Nasolabial Folds, and Edentulous Alveolar Ridges

Hybrid Course: 8 Hours Theory + 8 Hours Clinical Training

Includes supervised clinical practice on 6 patients

At Montréal AestheticS Academy (MASA), Level 4 introduces dentists to clinical dermal filler training after completion of the neuromodulator training pathway. This course is designed for licensed dentists who have completed MASA Levels 1, 2, and 3 and are ready to begin supervised training in selected dermal filler applications.

Level 4 focuses on the use of dermal fillers in key facial and dental-related regions, including the lips, vermilion border, nasolabial folds, and edentulous alveolar ridges. The course combines facial aesthetics, oral anatomy, smile design, patient safety, treatment planning, documentation, informed consent, and clinical application.

This is MASA’s first dermal filler certification level for dentists and is designed to support a structured educational pathway aligned with professional expectations for dental professionals.

​

Important Notice

Level 4 is intended for dentists who have successfully completed MASA Levels 1, 2, and 3.

This course focuses on selected dermal filler treatment areas appropriate to this training level. Advanced facial filler treatments outside the course objectives require additional training, clinical experience, and referral when appropriate.

​

Course Structure

​

Theory Component – 8 Hours

The theory component reviews facial anatomy, aging, dermal filler pharmacology, filler rheology, patient assessment, indications, contraindications, safety, complications, treatment planning, and documentation.

​

Clinical Component – 8 Hours

The clinical component includes supervised clinical training on 6 patients. Participants apply assessment, photography, treatment planning, informed consent, injection-site mapping, and selected dermal filler injection techniques under professional supervision.

​

What You Will Learn

​

1. Anatomy, Facial Aging, and Soft Tissue Assessment

Participants review the anatomical and structural principles required for safe dermal filler treatment planning.

Topics include:

• Facial aging changes involving skin, soft tissue, fat compartments, and bone support

• Functional and aesthetic anatomy of the lower face

• Lip anatomy and vermilion border assessment

• Perioral anatomy and smile dynamics

• Nasolabial fold anatomy

• Edentulous alveolar ridge considerations

• Vascular anatomy and high-risk zones

• Dermal layers and soft tissue support

• Facial balance and lower facial proportions

• Introduction to facial dissection principles through cadaver or virtual cadaver learning when available

​

2. Dermal Filler Pharmacology and Rheology

Participants learn the scientific principles that guide filler selection and clinical use.

Topics include:

• Overview of hyaluronic acid dermal fillers

• Introduction to alternative filler categories

• Filler rheology and tissue behavior

• Product selection based on treatment area

• Depth of placement and tissue integration

• Dosing considerations

• Longevity, degradation, and follow-up

• Combination planning with Botulinum Toxin Type A when appropriate

​

3. Patient Assessment and Diagnosis

This section focuses on evaluating patients before dermal filler treatment.

Assessment areas include:

• Lips

• Vermilion border

• Nasolabial folds

• Perioral region

• Edentulous alveolar ridges

• Smile aesthetics

• Facial volume and lower face support

Topics include:

• Medical history review

• Aesthetic and functional assessment

• Patient expectations and treatment goals

• Anatomical suitability

• Contraindications and precautions

• Baseline clinical photography

• Treatment limitations

• When to recommend alternative treatments or referral

​

4. Treatment Planning and Clinical Decision-Making

Participants learn how to build individualized treatment plans using dermal fillers within the scope of this training level.

Topics include:

• Treatment planning based on anatomy and patient goals

• Indications and contraindications for dermal fillers

• Alternatives to dermal fillers for facial rejuvenation

• Integration with dental treatment planning when relevant

• Combination planning with BoNT/A when appropriate

• Coordination with dental disciplines such as prosthodontics, orthodontics, periodontics, and oral and maxillofacial surgery

• Patient-specific product selection

• Risk assessment before treatment

• Referral pathways for advanced or interdisciplinary cases

​

5. Injection Planning and Techniques

Participants review and practice selected dermal filler injection techniques under supervision.

Treatment areas include:

• Lip enhancement and contour support

• Vermilion border definition

• Nasolabial fold correction

• Perioral support

• Edentulous alveolar ridge support when clinically appropriate

Techniques may include:

• Linear threading

• Micro-aliquot placement

• Cross-hatching

• Scaffolding

• Layered support techniques

• Volumetric contouring within selected treatment areas

• Site mapping and landmark identification

• Product dosing and placement depth

• Post-injection assessment and refinement

​

6. Edentulous Alveolar Ridge Applications

This section reviews selected dermal filler applications related to dental and orofacial care.

Topics include:

• Assessment of edentulous alveolar ridges

• Soft tissue support considerations

• Facial volume changes related to tooth loss

• Integration with denture planning when appropriate

• Limits of filler treatment in dental rehabilitation

• Referral or interdisciplinary collaboration when needed

​

7. Safety, Complication Prevention, and Adverse Event Management

Dermal filler treatments require strong knowledge of risk prevention, early recognition of complications, and appropriate management.

Topics include:

• Vascular anatomy and high-risk areas

• Prevention of vascular compromise

• Recognition of vascular occlusion symptoms

• Management pathways for suspected vascular events

• Bruising, swelling, and local reactions

• Nodules, lumps, or delayed inflammatory reactions

• Asymmetry or overcorrection

• Filler migration

• Infection prevention

• Emergency protocols

• Referral to specialists when indicated

​

8. Clinical Photography, Documentation, and Follow-Up

Participants learn how to document dermal filler treatments clearly and professionally.

Topics include:

• Standardized clinical photography

• Before-and-after documentation

• Treatment records

• Product name, lot number, expiry date, and volume used

• Injection-site charting

• Informed consent documentation

• Post-treatment instructions

• Follow-up evaluation

• Documentation of clinical outcomes, limitations, and adverse events

​

9. Patient Communication and Informed Consent

Clear communication is essential before any dermal filler treatment.

Topics include:

• Explaining treatment objectives

• Discussing benefits, risks, limitations, and alternatives

• Managing patient expectations

• Explaining variability of results

• Providing pre-treatment and post-treatment instructions

• Obtaining informed consent

• Communicating when treatment is not appropriate

• Discussing maintenance and follow-up care

​

10. Practice Integration and Team Preparation

This section reviews the clinical workflow required to safely integrate dermal filler treatments into a dental or aesthetic practice.

Topics include:

• Patient information sheets

• Staff preparation before and after treatment

• Treatment room preparation

• Infection prevention measures

• Clinical photography workflow

• Product storage and traceability

• Post-treatment patient support

• Emergency preparedness

• Legal, ethical, and professional considerations

​

Who This Course Is For

Level 4 is designed for licensed dentists who have completed MASA Levels 1, 2, and 3 and are ready to begin supervised clinical training in dermal fillers.

This course is appropriate for dentists interested in:

• Lip filler treatment planning

• Vermilion border definition

• Nasolabial fold correction

• Perioral support

• Edentulous alveolar ridge applications

• Smile aesthetics and lower face harmony

• Integration of injectable treatments into dental care planning

• Safe dermal filler injection principles

• Complication prevention and management

​

Course Objective

By the end of Level 4, participants will have developed a structured understanding of dermal filler use in selected facial and dental-related regions.

Participants will strengthen their knowledge of anatomy, facial aging, filler pharmacology, rheology, patient assessment, treatment planning, injection-site mapping, informed consent, documentation, complication prevention, and supervised clinical application.

This course provides the foundation for dentists who wish to responsibly integrate selected dermal filler treatments into aesthetic and dental-related practice settings.